Protocols
5 protocol(s) meet the specified criteria
Drug: ERBITUX
Protocol No.TitleStatus
201404139Phase I/II Trial of the Addition of PD 0332991 to Cetuximab in Patients with Incurable SCCHNOpen
LCCC1612P53 mutational status and circulating free HPV DNA for the management of HPV-associated Oropharyngeal Squamous Cell Cancers Open
LCCC1621Multimodality Therapy with induction Carboplatin/nab-Paclitaxel/Durvalumab followed by surgical resection followed by risk-adapted adjuvant therapy for the treatment of Locally-Advanced and Surgically Resectable Squamous Cell Carcinoma of the Head and Neck Open
LCCC1717Phase II study of the combination of palbociclib and cetuximab in KRAS/NRAS/BRAF wild-type metastatic colorectal cancerOpen
NC-6004-008Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and NeckOpen